{"id":"W6921278677","doi":"10.6084/m9.figshare.26710013","title":"Additional file 1 of NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Impact","funders":"","keywords":"Neratinib; Metastatic breast cancer; Breast cancer; Trastuzumab emtansine; Clinical trial; Phases of clinical research; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002797069,0.001041442,0.001576475,0.001634849,0.0009641929,0.001728668,0.001648687,0.001302245,0.8378676],"category_scores_gemma":[0.04451309,0.000699007,0.001450422,0.003701577,0.000309613,0.0017593,0.000876674,0.00109275,0.10644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001546465,"about_ca_system_score_gemma":0.003170188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006072605,"about_ca_topic_score_gemma":0.01072066,"domain_scores_codex":[0.9984964,0.0004062782,0.0003441311,0.000299171,0.0002669562,0.0001870906],"domain_scores_gemma":[0.9676404,0.02399984,0.003190534,0.001667708,0.002618031,0.000883535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.00253302,0.0001702164,0.002477935,0.006070901,0.0001940328,0.00008436399,0.00005366226,0.0006911061,0.00008879565,0.001272063,0.9742016,0.01216232],"study_design_scores_gemma":[0.06367695,0.001619437,0.03812227,0.01048299,0.001387975,0.001006071,0.0002952291,0.002568648,0.001101105,0.02145944,0.8580773,0.000202621],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"empirical","genre_scores_codex":[0.0002449969,0.00006124332,0.0002280538,0.0002139687,0.00002403243,0.0004111561,0.9965987,0.0001177849,0.002100004],"genre_scores_gemma":[0.02146548,0.000574195,0.004695066,0.002045134,0.0002949072,0.01680627,0.9272901,0.0006366855,0.02619221],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8378676,"threshold_uncertainty_score":0.2312621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08063681552332634,"score_gpt":0.4148627122325043,"score_spread":0.3342258967091779,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}